/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Latent class analysis of echocardiographic phenotypes predicts adverse outcomes and treatment response in heart failure with preserved ejection fraction
Event: Heart Failure 2019
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
Spironolactone reduces all-cause mortality in women but not men with heart failure with preserved ejection fraction enrolled in TOPCAT from the Americas
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: HFpEF - Heart failure with preserved ejection fraction
Session: Moderated Poster session 6 - Therapy
Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network
Event: HEART FAILURE 2016
Topic: Beta blockers
Session: Beta blockers
Association of anemia and transfusion with adverse outcomes in 22,991 patients hospitalized with takostsubo cardiomyopathy
Event: HEART FAILURE 2016
Topic: Cardiomyopathies
Session: Cardiomyopathy
Race differences in timing of presentation in 1137 peripartum cardiomyopathy patients compared with 2.1 million delivering mothers without peripartum cardiomyopathy
Event: HEART FAILURE 2016
Topic: Cardiomyopathies
Session: Cardiomyopathy
ESC 365 is supported by
